@article{7cf90d1a2e4f40539b15817c4702cdf4,
title = "Review of the Registry's Fourth Year, Incorporating Lead Data and Pediatric ICD Procedures, and Use as a National Performance Measure",
abstract = "The National ICD Registry is a successful partnership between HRS and ACCF collecting data from 486,025 ICD implantations from 1,434 hospitals and 5,246 implanting physicians during 2006-2009. Quarterly benchmarking reports are sent to each hospital allowing assessment of their outcomes from ICD implantation compared with hospitals of similar procedure volume and a national aggregate. Several important research studies have been published highlighting the use of ICDs in the general population outside the constraints of randomized clinical trials and assessing other procedural aspects that are associated with too small of volume to be adequately represented in randomized trials. A performance measure has been developed using the National ICD Registry and approved by the National Quality Forum and will be put in general use in early 2011. Version 2.0 of the Registry started accepting data in April 2010 and now collects data on leads associated with ICD implantation and pediatric ICD implants.",
author = "Hammill, {Stephen C.} and Kremers, {Mark S.} and Stevenson, {Lynne Warner} and Heidenreich, {Paul A.} and Lang, {Christine M.} and Curtis, {Jeptha P.} and Yongfei Wang and Berul, {Charles I.} and Kadish, {Alan H.} and Al-Khatib, {Sana M.} and Pina, {Ileana L.} and Walsh, {Mary Norine} and Mirro, {Michael J.} and Lindsay, {Bruce D.} and Reynolds, {Matthew R.} and Kathryn Pontzer and Laura Blum and Frederick Masoudi and John Rumsfeld and Brindis, {Ralph G.} and Donna Goldberg",
note = "Funding Information: For this reason the Longitudinal ICD Registry Study was developed by the National ICD Registry Working Group and approved by CMS in May 2007. The study is designed to follow a cohort of as many as 3,500 Medicare beneficiaries receiving a primary prevention ICD with a primary end point of the first delivery of an appropriate ICD therapy including either ICD shock or anti-tachycardia pacing. Secondary end points include survival at three and five years; death from any cardiovascular cause; total number and rate of device therapies; and ratio of inappropriate to total device therapy. The planned follow-up is three years for events and five years for survival with an adjudication process in place to review events. Funding for the Longitudinal ICD Registry Study was challenging but has been secured from the National Institute of Health, the Agency for Healthcare Research and Quality (AHRQ), and HRS/ACCF (through an unrestricted grant from industry). The study is being run by the CVRN, which is a national effort that leverages the collective cardiovascular expertise, diverse community based study population, and rich electronic data systems within the HMO Research Network to better study the epidemiology, prevention, management and outcomes of cardiovascular diseases. ",
year = "2010",
month = sep,
doi = "10.1016/j.hrthm.2010.07.015",
language = "English (US)",
volume = "7",
pages = "1340--1345",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "9",
}